Is nirogacestat available in the Chinese market?
Up to now, nirogacestat has not been officially launched in the Chinese market. Although the drug has been approved and put into clinical use in the United States, Europe and other places, due to the strictness of China's drug regulatory system, the launch time of many imported drugs will be affected by different factors.
Nilogastat is a targeted drug for desmoid tumors. Its main function is to inhibit the proliferation and growth of tumor cells by inhibiting the activity ofγ-secretase. Desmoid tumors are a progressive disease that mainly occurs in the abdomen or other tissues of adults. Although this tumor is usually benign, it can grow rapidly and affect the patient's quality of life. Therefore, as a new type of targeted therapy, nirogalastat has important clinical therapeutic potential.

Currently, nirogalastat has been approved in many countries and is already on the market in some foreign regions. The specification of the drug is usually 50 mg*180 tablets, and patients need to take it regularly according to the doctor's advice. Although the drug is not yet available in China, patients can obtain treatment by participating in clinical trials or purchasing drugs overseas.
Because nirogalastat is a new drug, its price varies between regions and sales channels. In the U.S. and European markets, prices may be higher, while in the Chinese market, information such as price and medical insurance coverage is unclear as the drug has not yet been approved. It is expected that as the domestic drug approval process advances, the drug may be introduced in the future.
If Chinese patients need to use Nilogastat, they can purchase it through cross-border drug purchase channels, participate in international clinical trials, or purchase through some medical platforms. In addition, as China gradually increases its support for drug approval in the treatment of rare diseases and desmoid tumors, the drug may enter the Chinese market in the next few years. Reference materials:https://www.drugs.com/mtm/nirogacestat.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)